Cefoperazone Sodium and Sulbactam Sodium (2:1) for Injection (注射用头孢哌酮钠舒巴坦钠(2:1))注射用头孢哌酮钠舒巴坦钠(2:1)
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
No product-level labeled indications/safety are joined for this record.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂
主要成分Active Ingredients
- 头孢哌酮钠 舒巴坦钠Recorded Chinese composition: 头孢哌酮钠 舒巴坦钠
- 头孢哌酮钠Toubao Paitong Na
- 舒巴坦钠Shuba Tanna
药物知识说明
头孢哌酮钠 舒巴坦钠是一种在国家药监局注册认定的药品。该药品含有头孢哌酮钠、头孢哌酮钠 舒巴坦钠、舒巴坦钠-35399356等成分。
该药品关联的活性成分包括：头孢哌酮钠Toubao Paitong Na、头孢哌酮钠 舒巴坦钠Recorded Chinese composition: 头孢哌酮钠 舒巴坦钠、舒巴坦钠Shuba Tanna。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂。
您可以探索含有相同成分的其他药品：头孢哌酮钠-f1e51bf2成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 注射用头孢哌酮钠舒巴坦钠(2:1)) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 头孢哌酮钠Toubao Paitong Na, 头孢哌酮钠 舒巴坦钠Recorded Chinese composition: Recorded Chinese name: 头孢哌酮钠 Recorded Chinese name: 舒巴坦钠, 舒巴坦钠Shuba Tanna.
Manufacturers recorded for this product: 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂.
Explore other medicines containing the same ingredient: 头孢哌酮钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 注射用头孢哌酮钠舒巴坦钠(2:1)Cefoperazone Sodium and Sulbactam Sodium (2:1) for Injection (注射用头孢哌酮钠舒巴坦钠(2:1))
- 商品名Trade name: 瑞普欣
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 1.0g(C25H27N9O8S2 0.5g与C8H11NO5S 0.5g)Recorded Chinese specification
- 命名冲突：来源不一致，以下仅展示已记录字段，未裁定唯一英文名。Name conflict across sources; showing recorded fields only; no invented English name.
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10970273
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (BLOCKED)Package-insert database (more than 100,000 records) (BLOCKED)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.